Comorbid substance use reduces the health care contacts of suicide attempters with schizophrenia spectrum or mood disorders

被引:8
|
作者
Suominen, KH
Isometsä, ET
Lönnqvist, JK
机构
[1] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, FIN-00300 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Psychiat, Jorvi Hosp, Espoo, Finland
关键词
attempted suicide; schizophrenia; mental disorders; health care; treatment; aftercare;
D O I
10.1093/oxfordjournals.schbul.a006970
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Utilization of health care services has been found to differ between psychiatric disorders. However, the pattern of health care contacts among suicide attempters with mental disorders is not known. This study systematically investigated the pattern of health care contacts among suicide attempters with schizophrenia spectrum versus mood disorders with or without comorbid substance use disorders both before and after attempted suicide. All consecutive medically treated suicide attempters in Helsinki from January 15, 1997, to January 14, 1998, were identified (n = 1,198). Data were gathered on all their health care contacts within the 12 months before and after the index attempt. Whereas the clear majority of all suicide attempters with schizophrenia spectrum or mood disorders had a treatment contact during the 30 days following the attempt, half of those with pure substance use disorders were without any contact with health care. Comorbid substance use made treatment less likely after attempted suicide among both psychiatric disorder groups; those with schizophrenia spectrum and comorbid substance use disorders were seven times more often left without aftercare recommendation than those without substance use comorbidity. Comorbid substance use disorders among suicide attempters with schizophrenia spectrum disorders decrease the likelihood of active aftercare, despite high suicide risk.
引用
收藏
页码:637 / 647
页数:11
相关论文
共 50 条
  • [1] Comparison of characteristics of suicide attempters with schizophrenia spectrum disorders and those with mood disorders in Japan
    Nakagawa, Makiko
    Kawanishi, Chiaki
    Yamada, Tomoki
    Sugiura, Kanna
    Iwamoto, Yoko
    Sato, Ryoko
    Morita, Satoshi
    Odawara, Toshinari
    Hirayasu, Yoshio
    [J]. PSYCHIATRY RESEARCH, 2011, 188 (01) : 78 - 82
  • [2] Suicide in personality disorders with substance use disorders comorbid
    Martinez Riera, R.
    Mateu Codina, G. -A.
    Diaz Digon, L.
    Castillo Buenaventura, C.
    Roig Llesuy, J.
    Vallecillo Sanchez, G.
    Morro Fernandez, L.
    Torrens Melich, M.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 73 - 73
  • [3] Treating comorbid substance use disorders in schizophrenia
    Lubman, Dan I.
    King, Joel A.
    Castle, David J.
    [J]. INTERNATIONAL REVIEW OF PSYCHIATRY, 2010, 22 (02) : 191 - 201
  • [4] Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review
    Prat, Gemma
    Marquez-Arrico, Julia E.
    Rio-Martinez, Laura
    Navarro, Jose Francisco
    Adan, Ana
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 110
  • [5] Characteristics of depressed suicide attempters with remitted substance use disorders
    Rizk, Mina M.
    Galfalvy, Hanga
    Miller, Jeffrey M.
    Milak, Matthew
    Parsey, Ramin
    Grunebaum, Michael
    Burke, Ainsley
    Sublette, M. Elizabeth
    Oquendo, Maria A.
    Stanley, Barbara
    Mann, J. John
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2021, 137 : 572 - 578
  • [6] Pharmacotherapy of comorbid mood, anxiety, and substance use disorders
    Brady, KT
    Verduin, ML
    [J]. SUBSTANCE USE & MISUSE, 2005, 40 (13-14) : 2021 - 2041
  • [7] Morbidity and mortality in schizophrenia with comorbid substance use disorders
    Lahteenvuo, Markku
    Batalla, Albert
    Luykx, Jurjen J.
    Mittendorfer-Rutz, Ellenor
    Tanskanen, Antti
    Tiihonen, Jari
    Taipale, Heidi
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2021, 144 (01) : 42 - 49
  • [8] Treatment of patients with schizophrenia and comorbid substance use disorders
    Dilbaz, Nesrin
    Darcin, Asli Enez
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 21 (01): : 80 - 90
  • [9] The spectrum of substance use in mood and anxiety disorders
    Sbrana, A
    Bizzarri, JV
    Rucci, P
    Gonnelli, C
    Doria, MR
    Spagnolli, S
    Ravani, L
    Raimondi, F
    Dell'Osso, LD
    Cassano, GB
    [J]. COMPREHENSIVE PSYCHIATRY, 2005, 46 (01) : 6 - 13
  • [10] A review of the neurobiological underpinning of comorbid substance use and mood disorders
    Gomez-Coronado, Nieves
    Sethi, Rickinder
    Bortolasci, Chiara Cristina
    Arancini, Lauren
    Berk, Michael
    Dodd, Seetal
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 241 : 388 - 401